Hantavirus in humans: a review of clinical aspects and management

Hantavirus infections are part of the broad group of viral haemorrhagic fevers. They are also recognised as a distinct model of an emergent zoonotic infection with a global distribution. Many factors influence their epidemiology and transmission, such as climate, environment, social development, eco...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The Lancet infectious diseases Ročník 23; číslo 9; s. e371 - e382
Hlavní autoři: Vial, Pablo A, Ferrés, Marcela, Vial, Cecilia, Klingström, Jonas, Ahlm, Clas, López, René, Le Corre, Nicole, Mertz, Gregory J
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Elsevier Ltd 01.09.2023
Elsevier Limited
Témata:
Algorithms
Antiviral drugs
Blood vessels
Clinical aspects
Disease
Endothelial cells
Epidemiology
Hantaviridae
Hantavirus
Hemorrhage
Hemorrhagic fever with renal syndrome
Infections
Infectious diseases
Pathogenesis
Permeability
RNA polymerase
Rodents
Serology
Viruses
Argentina
South Korea
Sweden
Asia
United States > US
Panama
Europe
China
Finland
Chile
Germany
Russia
ISSN:1473-3099, 1474-4457, 1474-4457
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Hantavirus infections are part of the broad group of viral haemorrhagic fevers. They are also recognised as a distinct model of an emergent zoonotic infection with a global distribution. Many factors influence their epidemiology and transmission, such as climate, environment, social development, ecology of rodent hosts, and human behaviour in endemic regions. Transmission to humans occurs by exposure to infected rodents in endemic areas; however, Andes hantavirus is unique in that it can be transmitted from person to person. As hantaviruses target endothelial cells, they can affect diverse organ systems; increased vascular permeability is central to pathogenesis. The main clinical syndromes associated with hantaviruses are haemorrhagic fever with renal syndrome (HFRS), which is endemic in Europe and Asia, and hantavirus cardiopulmonary syndrome (HCPS), which is endemic in the Americas. HCPS and HFRS are separate clinical entities, but they share several features and have many overlapping symptoms, signs, and pathogenic alterations. For HCPS in particular, clinical outcomes are highly associated with early clinical suspicion, access to rapid diagnostic testing or algorithms for presumptive diagnosis, and prompt transfer to a facility with critical care units. No specific effective antiviral treatment is available.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1473-3099
1474-4457
1474-4457
DOI:10.1016/S1473-3099(23)00128-7